Cardiac Sarcoidosis Randomized Trial
common.study.values.description
“Cardiac Sarcoidosis Randomized Trial”
Prospective randomized controlled trial comparing low dose Prednisone/Methotrexate combination to standard dose Prednisone in patients diagnosed with acute active clinically manifest cardiac sarcoidosis and not yet treated. The Investigators hypothesize that low dose Prednisone/Methotrexate combination will be as effective as standard dose Prednisone, and result in significantly better quality of life and less toxicity than standard dose Prednisone.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods


Drug - Prednisone
Oral prednisone tablet
Drug - Methotrexate
Oral, subcutaneous, or intramuscular methotrexate
participant.views.study.view.additional
participant.views.study.view.scientific-title
Cardiac Sarcoidosis Multi-Center Randomized Controlled Trial
common.study.values.clinical-trial-id
NCT03593759
participant.views.study.view.id
en55Wd